ABIO - ARCAバイオファ―マ (ARCA biopharma Inc.)


   Milestone Pharmaceuticals: At Phase 3 Of Development  2019-04-23
It is very likely that institutional investors will review the new IPO of Milestone Pharmaceuticals ( MIST ) closely. Besides, the company does not only have one product candidate at Phase 3 of development, it also raised more than $139 million through the sale of equity. Investors should reme…